Radiotherapy News and Research RSS Feed - Radiotherapy News and Research

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).
Study explores fitness training approach during breast cancer treatment in multi-sport athlete

Study explores fitness training approach during breast cancer treatment in multi-sport athlete

Professional athletes undergoing treatment for cancer often are in the headlines. [More]
Novel imaging agent can rapidly and accurately detect metastasis of prostate cancer

Novel imaging agent can rapidly and accurately detect metastasis of prostate cancer

New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of prostate cancer, even in areas where detection has previously been difficult. [More]
Researchers identify pathway that helps cancer cells to aggressively spread in the brain

Researchers identify pathway that helps cancer cells to aggressively spread in the brain

Glioblastoma multiforme remains the most common and highly lethal brain cancer and is known for its ability to relapse. [More]
SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

SMU virologist and cancer researcher Robert L. Harrod has been awarded a $436,500 grant from the National Cancer Institute to further his lab's research into how certain viruses cause cancers in humans. [More]
Suppressing bone specific protein can alleviate radiotherapy-induced osteoporosis

Suppressing bone specific protein can alleviate radiotherapy-induced osteoporosis

Radiotherapy destroys cancer cells using high-energy ionizing radiation to damage DNA and induce cell death. About two million patients per year in the United States - more than 50 percent of all cancer patients -- receive radiotherapy at some stage during their illness, either alone or in combination with chemotherapy, surgery, and targeted medicines. [More]
World Cancer Congress: DITTA urges development of integrated care approaches in medical technology

World Cancer Congress: DITTA urges development of integrated care approaches in medical technology

In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable. [More]
Authors call for international efforts to end preventable deaths from breast, cervical cancer

Authors call for international efforts to end preventable deaths from breast, cervical cancer

​Every year 800000 women die of cervical and breast cancer, but where a woman lives will largely determine her chance of survival. [More]
Research shows potential way to counteract glioblastoma growth by blocking PPARα receptor

Research shows potential way to counteract glioblastoma growth by blocking PPARα receptor

One of the most remarkable features of glioblastoma is the metabolic reprogramming of cancerous cells, resulting in uncontrolled cell proliferation, hypoxic conditions and angiogenesis. [More]
Scientists discover new option for treating malignant pleural mesothelioma

Scientists discover new option for treating malignant pleural mesothelioma

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma. [More]
Yale researchers identify chemical inhibitor that limits growth of lung tumor cells

Yale researchers identify chemical inhibitor that limits growth of lung tumor cells

A recently published Yale study may offer a new solution to fighting lung cancer. [More]
Standard hormone supplement after radiotherapy could increase risk of prostate cancer recurrence

Standard hormone supplement after radiotherapy could increase risk of prostate cancer recurrence

A new study at the University of York has shown that a standard hormone supplement, used to boost energy levels in prostate cancer patients following radiotherapy, could potentially increase the chances of the cancer returning. [More]
ASCO issues new global guideline on screening for cervical cancer

ASCO issues new global guideline on screening for cervical cancer

The American Society of Clinical Oncology today issued a new global guideline on screening for cervical cancer, one of the leading causes of cancer related death among women worldwide. [More]
Advanced Oncotherapy set to open first proton-beam cancer therapy unit in Harley Street, London

Advanced Oncotherapy set to open first proton-beam cancer therapy unit in Harley Street, London

A pioneering cancer treatment that causes minimal damage to surrounding cells will soon be available in the UK for global cancer patients to access. [More]
IMRT linked to reduced xerostomia and feeding tube dependency in oropharyngeal cancer patients

IMRT linked to reduced xerostomia and feeding tube dependency in oropharyngeal cancer patients

Radiation therapy is the main treatment modality in the management of head and neck cancer. [More]
Single high-intensity SBRT dose can be effective in treating early stage NSCLC patients

Single high-intensity SBRT dose can be effective in treating early stage NSCLC patients

Stereotactic body radiation therapy (SBRT) is a specialized and highly targeted method of delivering radiotherapy, or radiation therapy, to treat cancer. [More]
Study helps identify optimal treatment option for NSCLC patients with brain metastases

Study helps identify optimal treatment option for NSCLC patients with brain metastases

A Yale Cancer Center team completed a multi-institutional analysis of treatment options for patients with newly diagnosed EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases to determine the best option for treatment. [More]
Study reveals radiosurgery as viable treatment option for patients with resected brain metastases

Study reveals radiosurgery as viable treatment option for patients with resected brain metastases

For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life (QOL), compared to whole brain radiotherapy (WBRT), according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology. [More]
Researchers identify, validate three distinct molecular subtypes of prostate cancer

Researchers identify, validate three distinct molecular subtypes of prostate cancer

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to treatment, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology. [More]
Concord Medical's first proton therapy center to be installed at Beijing Proton Medical Center

Concord Medical's first proton therapy center to be installed at Beijing Proton Medical Center

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, is pleased to announce that its subsidiary, Medstar Leasing Co., Ltd, has signed a contract with IBA for the purchase, installation and maintenance of a proton therapy system, which will be installed at Beijing Proton Medical Center. [More]
Qfix launches new Symphony Patient Transport System to safely increase workflow efficiencies

Qfix launches new Symphony Patient Transport System to safely increase workflow efficiencies

Today, Qfix, a world leader in radiotherapy patient positioning devices, announced it is launching the new Symphony Patient Transport System that maximizes workflow efficiencies and throughput by seamlessly aiding in the setup, positioning and transfer of a patient for procedures involving imaging, external beam radiation therapy, brachytherapy and other procedures requiring the transfer of a patient. [More]
Advertisement
Advertisement